Simon Maksour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Simon Maksour has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Lezanne Ooi
School of Science and Molecular Horizons, University of Wollongong, Wollongong, Australia
8 shared publications - Mirella Dottori
Molecular Horizons, School of Medical and Indigenous Health Sciences, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia
7 shared publications - Amy J. Hulme
Molecular Horizons, School of Medical and Indigenous Health Sciences, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia
4 shared publications Martin Engel
Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Northfields Avenue, Wollongong, NSW, 2522, Australia
3 shared publications- Neville S. Ng
Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia
3 shared publications - Rachelle Balez
Molecular Horizons and School of Chemistry and Molecular Bioscience University of Wollongong Wollongong, NSW Australia
3 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in Cell Death & Disease
Phenotypic screening in ALS motor neurons identifies SIRT1 activation as a genotype-independent neuroprotective strategy
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterised by motor neuron degeneration and intrinsic neuronal hyperexcitability, with a lack of disease modifying treatments. One of the major challenges in therapeutic development for ALS is the genetic heterogeneity. Thus, there is a pressing need for human models of sporadic and familial ALS that enable identification of convergent, genotype-independent neuroprotective mechanisms that correct multiple ALS-associated phenotypes. This study screened spinal motor neurons generated from sporadic and familial ALS donor induced pluripotent stem cells (iPSCs) with 512 natural products isolated from fungal, plant and marine invertebrate sources. We utilised live cell imaging, whole cell patch clamp and proteomics to identify compounds that could protect against neuronal degeneration, neurite damage and intrinsic hyperexcitability in ALS motor neurons. Two resveratrol tetramers isolated from a Papua New Guinean rainforest canopy tree, vaticanol B and (-)-hopeaphenol, protected against neuronal degeneration and neurite damage across genotypes. Both tetramers were more potent than resveratrol, a well-characterised SIRT1 activator, with (-)-hopeaphenol exhibiting the greatest effects. (-)-hopeaphenol conferred broad neuroprotection in an expanded cohort of sporadic and familial ALS motor neurons spanning TARDBP, SOD1 , or C9ORF72 genotypes ( n = 14 iPSC lines). Additionally, (-)-hopeaphenol treatment protected against intrinsic hyperexcitability, reversing aberrant increases in Na + currents and alterations in repetitive firing. As a pathway to clinical translation, we showed SRT2104, a second generation SIRT1 activator with blood-brain barrier permeability and tolerability in humans, protected against neurite degeneration, ALS-related hyperexcitability changes and upregulated neuroprotective pathways at threefold lower concentration than (-)-hopeaphenol. These results provide proof-of-concept that SIRT1 activation in motor neurons offers a convergent, genotype-independent neuroprotective strategy for ALS.
- 31 October 2026
- Published by Springer Nature in Cell Death & Disease
Open AccessPhenotypic screening in ALS motor neurons identifies SIRT1 activation as a genotype-independent neuroprotective strategy
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterised by motor neuron degeneration and intrinsic neuronal hyperexcitability, with a lack of disease modifying treatments. One of the major challenges in therapeutic development for ALS is the genetic heterogeneity. Thus, there is a pressing need for human models of sporadic and familial ALS that enable identification of convergent, genotype-independent neuroprotective mechanisms that correct multiple ALS-associated phenotypes. This study screened spinal motor neurons generated from sporadic and familial ALS donor induced pluripotent stem cells (iPSCs) with 512 natural products isolated from fungal, plant and marine invertebrate sources. We utilised live cell imaging, whole cell patch clamp and proteomics to identify compounds that could protect against neuronal degeneration, neurite damage and intrinsic hyperexcitability in ALS motor neurons. Two resveratrol tetramers isolated from a Papua New Guinean rainforest canopy tree, vaticanol B and (-)-hopeaphenol, protected against neuronal degeneration and neurite damage across genotypes. Both tetramers were more potent than resveratrol, a well-characterised SIRT1 activator, with (-)-hopeaphenol exhibiting the greatest effects. (-)-hopeaphenol conferred broad neuroprotection in an expanded cohort of sporadic and familial ALS motor neurons spanning TARDBP, SOD1 , or C9ORF72 genotypes ( n = 14 iPSC lines). Additionally, (-)-hopeaphenol treatment protected against intrinsic hyperexcitability, reversing aberrant increases in Na + currents and alterations in repetitive firing. As a pathway to clinical translation, we showed SRT2104, a second generation SIRT1 activator with blood-brain barrier permeability and tolerability in humans, protected against neurite degeneration, ALS-related hyperexcitability changes and upregulated neuroprotective pathways at threefold lower concentration than (-)-hopeaphenol. These results provide proof-of-concept that SIRT1 activation in motor neurons offers a convergent, genotype-independent neuroprotective strategy for ALS.
- Open Access
TriPort tangential flow filtration: a lab-assembled system for EV isolation across diverse cell-culture sources
Tangential flow filtration (TFF) is an effective method for scalable EV isolation. Here, we describe and validate a reference protocol for TriPort-TFF, a laboratory-assembled TFF system featuring a three-port reservoir design enabling sample circulation, retentate return, and diafiltration. Constructed from individually sourced, commercially available components with detailed assembly and operating parameters, TriPort-TFF can be built at a lower cost than commercially integrated TFF platforms. We evaluated the system using conditioned media (CM) from human MDM cultured with EV-depleted human serum, human cerebral organoids in serum-free medium, and mouse BMDM cultured with EV-depleted foetal bovine serum (FBS) unstimulated or LPS-stimulated. The system reproducibly isolated EVs from all three sources, and biological replicates of BMDM showed distinct proteomic clusters between LPS-stimulated and unstimulated conditions. The requirement for subsequent size-exclusion chromatography (SEC) after TFF depended on the sample’s serum-presence. In serum-containing CM, TFF alone co-concentrated serum proteins alongside EVs, subsequent SEC improved the particle-to-protein ratio, reduced inter-replicate variability and improved proteomic depth. TFF alone in serum-free organoid CM already yielded higher particle-to-protein ratios than TFF-only preparations from serum-containing CM, with SEC further improving this ratio. TriPort-TFF offers an accessible system for EV-isolation that can be combined with SEC for diverse sample types.
Open AccessTriPort tangential flow filtration: a lab-assembled system for EV isolation across diverse cell-culture sources
Tangential flow filtration (TFF) is an effective method for scalable EV isolation. Here, we describe and validate a reference protocol for TriPort-TFF, a laboratory-assembled TFF system featuring a three-port reservoir design enabling sample circulation, retentate return, and diafiltration. Constructed from individually sourced, commercially available components with detailed assembly and operating parameters, TriPort-TFF can be built at a lower cost than commercially integrated TFF platforms. We evaluated the system using conditioned media (CM) from human MDM cultured with EV-depleted human serum, human cerebral organoids in serum-free medium, and mouse BMDM cultured with EV-depleted foetal bovine serum (FBS) unstimulated or LPS-stimulated. The system reproducibly isolated EVs from all three sources, and biological replicates of BMDM showed distinct proteomic clusters between LPS-stimulated and unstimulated conditions. The requirement for subsequent size-exclusion chromatography (SEC) after TFF depended on the sample’s serum-presence. In serum-containing CM, TFF alone co-concentrated serum proteins alongside EVs, subsequent SEC improved the particle-to-protein ratio, reduced inter-replicate variability and improved proteomic depth. TFF alone in serum-free organoid CM already yielded higher particle-to-protein ratios than TFF-only preparations from serum-containing CM, with SEC further improving this ratio. TriPort-TFF offers an accessible system for EV-isolation that can be combined with SEC for diverse sample types.
- Open Access
Optimizing the In Vitro Neuronal Microenvironment to Mitigate Phototoxicity in Live-cell Imaging
Long-term imaging formats are ideal for capturing dynamic neuronal network formation in vitro, yet fluorescent techniques are often constrained by the impact of phototoxicity on cell survival. Here we present a live-imaging protocol that was optimised via quantitative analysis of 3 target culturing conditions on neuromorphological health: extracellular matrix (human- versus murine-derived laminin), culture media (Neurobasal™ versus Brainphys™ Imaging media), and seeding density (1×10 5 versus 2×10 5 cells/cm 2 ). A cortical neuron reporter line was differentiated from human embryonic stem cells by transduction of Neurogenin-2 and green fluorescent protein, then fluorescently imaged in 8 different microenvironments daily for 33 days. Alongside viability analysis by PrestoBlue assay and gene quantification by digital polymerase chain reaction, an automated image analysis pipeline was developed to characterise network morphology and organisation over time. Brainphys™ Imaging medium was observed to support neuron viability, outgrowth, and self-organisation to a greater extent than Neurobasal™ medium with either laminin type, while the combination of Neurobasal™ medium and human laminin reduced cell survival. Further, a higher seeding density fostered somata clustering, but did not significantly extend viability compared to low density. These findings suggest a synergistic relationship between species-specific laminin and culture media in phototoxic environments, which is positively mediated by light-protective compounds found in Brainphys™ Imaging medium.
Open AccessOptimizing the In Vitro Neuronal Microenvironment to Mitigate Phototoxicity in Live-cell Imaging
Long-term imaging formats are ideal for capturing dynamic neuronal network formation in vitro, yet fluorescent techniques are often constrained by the impact of phototoxicity on cell survival. Here we present a live-imaging protocol that was optimised via quantitative analysis of 3 target culturing conditions on neuromorphological health: extracellular matrix (human- versus murine-derived laminin), culture media (Neurobasal™ versus Brainphys™ Imaging media), and seeding density (1×10 5 versus 2×10 5 cells/cm 2 ). A cortical neuron reporter line was differentiated from human embryonic stem cells by transduction of Neurogenin-2 and green fluorescent protein, then fluorescently imaged in 8 different microenvironments daily for 33 days. Alongside viability analysis by PrestoBlue assay and gene quantification by digital polymerase chain reaction, an automated image analysis pipeline was developed to characterise network morphology and organisation over time. Brainphys™ Imaging medium was observed to support neuron viability, outgrowth, and self-organisation to a greater extent than Neurobasal™ medium with either laminin type, while the combination of Neurobasal™ medium and human laminin reduced cell survival. Further, a higher seeding density fostered somata clustering, but did not significantly extend viability compared to low density. These findings suggest a synergistic relationship between species-specific laminin and culture media in phototoxic environments, which is positively mediated by light-protective compounds found in Brainphys™ Imaging medium.
- Open Access
Distinct molecular and functional properties of human induced-proprioceptor and low-threshold mechanoreceptor neurons
Sensing mechanical stimuli is crucial for the function of internal and external tissues, such as the skin and muscles. Much of our understanding of mechanosensory physiology relies on rodent studies, which may not directly translate to humans. To address the knowledge gap in human mechanosensation, we developed distinct populations of human mechanosensory neuronal subtypes from human pluripotent stem cells (hPSC). By inducing co-expression of NGN2/RUNX3 or NGN2/SHOX2 in hPSC-derived migrating neural crest cells we directed their specification to proprioceptor and low-threshold mechanoreceptor neuronal subtypes, respectively. The induced neurons exhibited transcriptional profiles consistent with mechanosensory neurons and displayed functional responses to mechanical stimuli, such as stretch and submicrometer probe indentation to the soma. Notably, each subtype displayed unique mechanical thresholds and desensitization properties akin to proprioceptors and low-threshold mechanoreceptors and both induced neuronal subtypes fired action potentials in response to minute mechanical stimuli, predominantly relying on PIEZO2 for mechanosensory function. Collectively, this study provides a foundational model for exploring human neuronal mechanosensory biology.
Open AccessDistinct molecular and functional properties of human induced-proprioceptor and low-threshold mechanoreceptor neurons
Sensing mechanical stimuli is crucial for the function of internal and external tissues, such as the skin and muscles. Much of our understanding of mechanosensory physiology relies on rodent studies, which may not directly translate to humans. To address the knowledge gap in human mechanosensation, we developed distinct populations of human mechanosensory neuronal subtypes from human pluripotent stem cells (hPSC). By inducing co-expression of NGN2/RUNX3 or NGN2/SHOX2 in hPSC-derived migrating neural crest cells we directed their specification to proprioceptor and low-threshold mechanoreceptor neuronal subtypes, respectively. The induced neurons exhibited transcriptional profiles consistent with mechanosensory neurons and displayed functional responses to mechanical stimuli, such as stretch and submicrometer probe indentation to the soma. Notably, each subtype displayed unique mechanical thresholds and desensitization properties akin to proprioceptors and low-threshold mechanoreceptors and both induced neuronal subtypes fired action potentials in response to minute mechanical stimuli, predominantly relying on PIEZO2 for mechanosensory function. Collectively, this study provides a foundational model for exploring human neuronal mechanosensory biology.
- Open Access
Alzheimer’s disease induced neurons bearing PSEN1 mutations exhibit reduced excitability
Alzheimer’s disease (AD) is a devastating neurodegenerative condition that affects memory and cognition, characterized by neuronal loss and currently lacking a cure. Mutations in PSEN1 (Presenilin 1) are among the most common causes of early-onset familial AD (fAD). While changes in neuronal excitability are believed to be early indicators of AD progression, the link between PSEN1 mutations and neuronal excitability remains to be fully elucidated. This study examined induced pluripotent stem cell (iPSC)-derived NGN2 induced neurons (iNs) from fAD patients with PSEN1 mutations S290C or A246E, alongside CRISPR-corrected isogenic cell lines, to investigate early changes in excitability. Electrophysiological profiling revealed reduced excitability in both PSEN1 mutant iNs compared to their isogenic controls. Neurons bearing S290C and A246E mutations exhibited divergent passive membrane properties compared to isogenic controls, suggesting distinct effects of PSEN1 mutations on neuronal excitability. Additionally, both PSEN1 backgrounds exhibited higher current density of voltage-gated potassium (Kv) channels relative to their isogenic iNs, while displaying comparable voltage-gated sodium (Nav) channel current density. This suggests that the Nav/Kv imbalance contributes to impaired neuronal firing in fAD iNs. Deciphering these early cellular and molecular changes in AD is crucial for understanding the disease pathogenesis.
Open AccessAlzheimer’s disease induced neurons bearing PSEN1 mutations exhibit reduced excitability
Alzheimer’s disease (AD) is a devastating neurodegenerative condition that affects memory and cognition, characterized by neuronal loss and currently lacking a cure. Mutations in PSEN1 (Presenilin 1) are among the most common causes of early-onset familial AD (fAD). While changes in neuronal excitability are believed to be early indicators of AD progression, the link between PSEN1 mutations and neuronal excitability remains to be fully elucidated. This study examined induced pluripotent stem cell (iPSC)-derived NGN2 induced neurons (iNs) from fAD patients with PSEN1 mutations S290C or A246E, alongside CRISPR-corrected isogenic cell lines, to investigate early changes in excitability. Electrophysiological profiling revealed reduced excitability in both PSEN1 mutant iNs compared to their isogenic controls. Neurons bearing S290C and A246E mutations exhibited divergent passive membrane properties compared to isogenic controls, suggesting distinct effects of PSEN1 mutations on neuronal excitability. Additionally, both PSEN1 backgrounds exhibited higher current density of voltage-gated potassium (Kv) channels relative to their isogenic iNs, while displaying comparable voltage-gated sodium (Nav) channel current density. This suggests that the Nav/Kv imbalance contributes to impaired neuronal firing in fAD iNs. Deciphering these early cellular and molecular changes in AD is crucial for understanding the disease pathogenesis.
- Open Access
REST and RCOR genes display distinct expression profiles in neurons and astrocytes using 2D and 3D human pluripotent stem cell models
Repressor element-1 silencing transcription factor (REST) is a transcriptional repressor involved in neurodevelopment and neuroprotection. REST forms a complex with the REST corepressors, CoREST1, CoREST2, or CoREST3 (encoded by RCOR1 , RCOR2 , and RCOR3 , respectively). Emerging evidence suggests that the CoREST family can target unique genes independently of REST, in various neural and glial cell types during different developmental stages. However, there is limited knowledge regarding the expression and function of the CoREST family in human neurodevelopment. To address this gap, we employed 2D and 3D human pluripotent stem cell (hPSC) models to investigate REST and RCOR gene expression levels. Our study revealed a significant increase in RCOR3 expression in glutamatergic cortical and GABAergic ventral forebrain neurons, as well as mature functional NGN2-induced neurons. Additionally, a simplified astrocyte transdifferentiation protocol resulted in a significant decrease in RCOR2 expression following differentiation. REST expression was notably reduced in mature neurons and cerebral organoids, along with RCOR2 in the latter. In summary, our findings provide the first insights into the cell-type-specific expression patterns of RCOR genes in human neuronal and glial differentiation. Specifically, RCOR3 expression increases in neurons, while RCOR2 levels decrease in astrocytes. The dynamic expression patterns of REST and RCOR genes during hPSC neuronal and glial differentiation underscore the potential distinct roles played by REST and CoREST proteins in regulating the development of these cell types in humans. Graphical Highlights: REST and RCOR genes display cell-type specific expression patterns in neural cells RCOR3 (encodes CoREST3) is upregulated during neuronal and astrocyte differentiation RCOR2 (encodes CoREST2) is downregulated during differentiation of astrocytes Evidence of potential cell-type specific functions of the CoREST family
Open AccessREST and RCOR genes display distinct expression profiles in neurons and astrocytes using 2D and 3D human pluripotent stem cell models
Repressor element-1 silencing transcription factor (REST) is a transcriptional repressor involved in neurodevelopment and neuroprotection. REST forms a complex with the REST corepressors, CoREST1, CoREST2, or CoREST3 (encoded by RCOR1 , RCOR2 , and RCOR3 , respectively). Emerging evidence suggests that the CoREST family can target unique genes independently of REST, in various neural and glial cell types during different developmental stages. However, there is limited knowledge regarding the expression and function of the CoREST family in human neurodevelopment. To address this gap, we employed 2D and 3D human pluripotent stem cell (hPSC) models to investigate REST and RCOR gene expression levels. Our study revealed a significant increase in RCOR3 expression in glutamatergic cortical and GABAergic ventral forebrain neurons, as well as mature functional NGN2-induced neurons. Additionally, a simplified astrocyte transdifferentiation protocol resulted in a significant decrease in RCOR2 expression following differentiation. REST expression was notably reduced in mature neurons and cerebral organoids, along with RCOR2 in the latter. In summary, our findings provide the first insights into the cell-type-specific expression patterns of RCOR genes in human neuronal and glial differentiation. Specifically, RCOR3 expression increases in neurons, while RCOR2 levels decrease in astrocytes. The dynamic expression patterns of REST and RCOR genes during hPSC neuronal and glial differentiation underscore the potential distinct roles played by REST and CoREST proteins in regulating the development of these cell types in humans. Graphical Highlights: REST and RCOR genes display cell-type specific expression patterns in neural cells RCOR3 (encodes CoREST3) is upregulated during neuronal and astrocyte differentiation RCOR2 (encodes CoREST2) is downregulated during differentiation of astrocytes Evidence of potential cell-type specific functions of the CoREST family
- Open Access
- 15 June 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 166 (3) , 497-516
Innovations advancing our understanding of microglia in Alzheimer's disease: From in vitro to in vivo models
Microglia have been implicated in Alzheimer's disease (AD) pathogenesis through the identification of risk factor genes that are specifically or predominantly expressed in this cell type. Additional evidence suggests that microglia undergo dramatic morphological and phenotypic state changes during AD progression, as observed in human post‐mortem tissue and animal model research. Although valuable, these studies are often hampered by either representing one time point in human tissue (end point) or because of the lack of conservation between species of microglial transcriptomes, proteomes and cell states. Thus, the development and application of novel human model systems have been beneficial in the study of microglia in neurodegeneration. Recent innovations include the use of human pluripotent stem cell (hPSC)‐derived microglia in 2D or 3D culture systems, the transdifferentiation of microglia from patient monocytes and the xenotransplantation of hPSC‐derived microglia into mouse brains. This review summarizes the recent innovations that have advanced our understanding of microglia in AD, through the use of single‐cell RNA sequencing, hPSC‐derived microglia culture within brain organoids and xenotransplantation into mouse brain. Through outlining the strengths and limitations of these approaches, we provide recommendations that will aid future endeavours in advancing our understanding of the complex role of microglia in AD onset and progression. image
- 15 June 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 166 (3) , 497-516
Open AccessInnovations advancing our understanding of microglia in Alzheimer's disease: From in vitro to in vivo models
Microglia have been implicated in Alzheimer's disease (AD) pathogenesis through the identification of risk factor genes that are specifically or predominantly expressed in this cell type. Additional evidence suggests that microglia undergo dramatic morphological and phenotypic state changes during AD progression, as observed in human post‐mortem tissue and animal model research. Although valuable, these studies are often hampered by either representing one time point in human tissue (end point) or because of the lack of conservation between species of microglial transcriptomes, proteomes and cell states. Thus, the development and application of novel human model systems have been beneficial in the study of microglia in neurodegeneration. Recent innovations include the use of human pluripotent stem cell (hPSC)‐derived microglia in 2D or 3D culture systems, the transdifferentiation of microglia from patient monocytes and the xenotransplantation of hPSC‐derived microglia into mouse brains. This review summarizes the recent innovations that have advanced our understanding of microglia in AD, through the use of single‐cell RNA sequencing, hPSC‐derived microglia culture within brain organoids and xenotransplantation into mouse brain. Through outlining the strengths and limitations of these approaches, we provide recommendations that will aid future endeavours in advancing our understanding of the complex role of microglia in AD onset and progression. image
- Open Access
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S188-S189
237. The Effect of Sertraline and Voluntary Exercise During Pregnancy on Maternal Anxiety-Like Behaviours and Cortical and Hippocampal Gene Expression
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S188-S189
Open Access237. The Effect of Sertraline and Voluntary Exercise During Pregnancy on Maternal Anxiety-Like Behaviours and Cortical and Hippocampal Gene Expression
- Open Access
- 26 May 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (6) , 364
An Optimized Direct Lysis Gene Expression Microplate Assay and Applications for Disease, Differentiation, and Pharmacological Cell-Based Studies
Routine cell culture reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) gene expression analysis is limited in scalability due to minimum sample requirement and multistep isolation procedures. In this study, we aimed to optimize and apply a cost-effective and rapid protocol for directly sampling gene expression data from microplate cell cultures. The optimized protocol involves direct lysis of microplate well population followed by a reduced thermocycler reaction time one-step RT-qPCR assay. In applications for inflammation and stress-induced cell-based models, the direct lysis RT-qPCR microplate assay was utilized to detect IFN1 and PPP1R15A expression by poly(I:C) treated primary fibroblast cultures, IL6 expression by poly(I:C) iPSC-derived astrocytes, and differential PPP1R15A expression by ER-stressed vanishing white-matter disease patient induced pluripotent stem cell (iPSC)-derived astrocytes. In application for neural differentiation medium recipe optimizations, conditions were screened for SYN1 and VGLUT1 in neuronal cultures, and S100B, GFAP and EAAT1 in astrocyte cultures. The protocol provides microplate gene expression results from cell lysate to readout within ~35 min, with comparable cost to routine RT-qPCR, and it may be utilized to support laboratory cell-based assays in basic and applied scientific and medical fields of research including stem-cell differentiation, cell physiology, and drug mechanism studies.
- 26 May 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (6) , 364
Open AccessAn Optimized Direct Lysis Gene Expression Microplate Assay and Applications for Disease, Differentiation, and Pharmacological Cell-Based Studies
Routine cell culture reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) gene expression analysis is limited in scalability due to minimum sample requirement and multistep isolation procedures. In this study, we aimed to optimize and apply a cost-effective and rapid protocol for directly sampling gene expression data from microplate cell cultures. The optimized protocol involves direct lysis of microplate well population followed by a reduced thermocycler reaction time one-step RT-qPCR assay. In applications for inflammation and stress-induced cell-based models, the direct lysis RT-qPCR microplate assay was utilized to detect IFN1 and PPP1R15A expression by poly(I:C) treated primary fibroblast cultures, IL6 expression by poly(I:C) iPSC-derived astrocytes, and differential PPP1R15A expression by ER-stressed vanishing white-matter disease patient induced pluripotent stem cell (iPSC)-derived astrocytes. In application for neural differentiation medium recipe optimizations, conditions were screened for SYN1 and VGLUT1 in neuronal cultures, and S100B, GFAP and EAAT1 in astrocyte cultures. The protocol provides microplate gene expression results from cell lysate to readout within ~35 min, with comparable cost to routine RT-qPCR, and it may be utilized to support laboratory cell-based assays in basic and applied scientific and medical fields of research including stem-cell differentiation, cell physiology, and drug mechanism studies.